In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Molecular Biometrics Inc.

www.molecularbiometrics.com

Latest From Molecular Biometrics Inc.

Safeguard Jumps Into Life Science But Leaves Behind Early-Stage Risk

With two major exits and a third pending, the traditionally high-tech-heavy investor's new strategy is paying off. Safeguard's lower appetite for risk in the life sciences means focusing on companies with existing or near-term revenues, cash flow, and net worth being built up, rather than dependence on a regulatory or clinical milestone as an inflection point. The firm also boasts an ability to bolster the management and operational capabilities of its young companies.
United States Business Strategies

Start-Up News

Noteworthy news from medtech start-ups. This month we profile Auxogyn, which is developing imaging tools for improving success rates for in vitro fertilization, and Urovalve, which has developed patient-activated bladder management technology.
Medical Device

The A-List: 2010's Trend-Shaping Series A Financings

Investments for start-ups seeking their first infusion of venture capital continues to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising new funds.

Auxogyn Inc.

Auxogyn Inc. believes it has found a way to increase the success rate of in vitro fertilization procedures. Its new, noninvasive imaging technology is designed to provide novel data regarding the viability of an embryo, and using time-lapse imaging, will allow embryologists to determine which embryos have the highest likelihood of developing into blastocytes and result in a health pregnancy.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Molecular Biometrics LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Molecular Biometrics Inc.
  • Senior Management
  • James T Posillico, PhD, Pres. & CEO
    Thomas J Coffey, Dir., Fin.
    Robert B Rochelle, VP, Mktg. & Bus. Dev.
    Denny Sakkas, PhD, CSO
  • Contact Info
  • Molecular Biometrics Inc.
    Phone: (781) 501-5600
    1 Edgewater Dr.
    Ste. 110
    Norwood, MA 02062
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register